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, as routinely performed in our laboratory [6, 25] .
Experimental Animals
Male C57BL/6J mice (∼20 g, 6-7 weeks old) obtained from Jackson Laboratory (Bar Harbor, ME), were injected streptozotocin (STZ, 55 mg/kg) for 5 consecutive days [1, 25] . Those mice presenting with a blood glucose concentration of 14 mmol/l or higher, 1 day after the last injection of STZ, were considered to be diabetic. A group of diabetic mice was administered NSC23766 (2.5 mg kg −1 day −1 , i.p; Sigma-Aldrich, St. Louis, MO) soon after establishment of diabetes. The mice were killed 2 weeks after initiation of NSC23766 treatment by carbon dioxide asphyxiation and one eye was used to isolate the retina and frozen immediately in liquid nitrogen for biochemical analysis, and the other eye was incubated in 10% formaldehyde for 30 min, washed with PBS, fixed in optimal cutting temperature compound (OCT), and frozen in liquid nitrogen for sectioning and immunostaining [26] . Age-matched normal mice served as controls. The treatment of the animals conformed to the Association for Research in Vision and Ophthalmology Resolution on the Use of Animals in Research, and institutional guidelines. The majority of small G-proteins (e.g., members of Rho subfamily, Rac1) undergo a series of post-translational modifications at their C-termini, including prenylation and carboxylmethylation [8] [9] [10] [11] 46 ]. In addition, certain G-proteins (Rac1) have also been shown to undergo palmitoylation, catalyzed by protein acyltransferase, at a cysteine residue, which is upstream to the prenylated cysteine. Palmitoylation provides a "firm" anchoring for the modified protein into the cell membrane for optimal interaction with its respective effector proteins [8] [9] [10] [11] 46] . Depalmitoylation of these proteins is catalyzed by acyl protein thioesterase. Recent evidence implicates that palmitoylation also promotes Rac1 activation (GTP-bound conformation). Also shown here is activation-deactivation cycle for Rac1. Exchange of GDP for GTP is mediated by Tiam1, a known, guanine nucleotide exchange factor for Rac1. In the current study, we examined putative roles of Tiam1-Rac1 axis (NSC23766) and protein palmitoylation (2-bromopalmitate; 2-BP) in glucose-induced p38 MAP kinase phosphorylation and activation (see text for additional details). Abbreviations used are: Rac1: Ras-related C3 botulinum toxin substrate 1; Rac1-GDP: Rac1 bound to guanosine diphosphate [inactive]; Rac1-GTP: Rac1 bound to guanosine triphosphate; GAP: GTPase activating protein; GDI: guanosine diphosphate dissociation inhibitor; and Tiam1: T-cell lymphoma invasion and metastasis 1.
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Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry p38 MAP kinase activation Activation of p38 MAP kinase was determined by Western blotting in retinal endothelial cells incubated under various experimental conditions using an antibody raised against a short amino acid sequence containing dually phosphorylated Thr 180/Tyr 182 of p38α (Santa Cruz Biotechnology, Santa Cruz, CA). The same blots were stripped and re-probed with total p38 MAP kinase (Santa Cruz Biotechnology, Santa Cruz, CA). Relative intensities of the bands were quantified by densitometry.
Nox2 activity
Nox2 activity was measured in the cell homogenate by luminescence assay using 20 μM lucigenin as electron acceptor and 100 μM NADPH [6, 27, 28] .
Rac1 activation assay:
Rac1 activation was quantified using a G-LISA assay kit (Cytoskeleton Inc., Denver, CO) as described in [13, 29] .
ROS generation assay
Total ROS levels were measured fluorometrically by incubating 5 μg of protein with 2 μmol/l of 2',7' dichlorofluorescein diacetate, DCHFDA (Sigma-Aldrich, St. Louis, MO) for 10 minutes. The fluorescence was measured at 485 nm and 530 nm as excitation and emission wavelengths, respectively [6] .
Mitochondrial DNA damage Extended length PCR was performed by amplifying long (13.4kb) and short (210bp) regions of mtDNA. Total DNA was isolated using DNeasy blood and tissue kit (Qiagen, Valencia, CA), and the ratio between the intensity of the long to short fragment of PCR amplicons was calculated [5, 6, 30] .
Quantification of cell apoptosis
Apoptosis was performed using an ELISA kit from Roche Diagnostics (Indianapolis, IN) as routinely used in our laboratory. Briefly, mono-and oligonucleosomes generated from the apoptotic cells were quantified using monoclonal antibodies directed against DNA and histones respectively. Using 2,2'-Azinodi-[3-ethylbenzthiazoline sulfonate] diammonium salt, the absorbance generated was measured at 405 nm [6, 25] .
Immunostaining of retinal cryosections
Mouse retina cryosections (10 µm) were fixed in 4% paraformaldehyde and blocked with 10% normal goat serum. The sections were rinsed with PBS, permeabilized with 0.1% Triton X-100, and incubated over night with anti-p38 antibody (rabbit polyclonal, ab7952, Abcam; Cambridge, MA). The slides were rinsed with PBS, and incubated with the anti-rabbit-FITC conjugated secondary antibody (NL006; R&D systems; Minneapolis, MN) for 1 hour [26] . After rinsing the slides with PBS, the sections were mounted with DAPIcontaining mounting media (Vector Laboratories; Burlingame, CA), and imaged with an Olympus BX-UCB fluorescent microscope (20X magnification). The fluorescence intensity was quantified by using ImageJ software (version 1.44; NIH). Cryosections processed under similar conditions, except being incubated with the primary antibody, served as controls.
Statistical analysis of experimental data
Statistical analysis was carried out using Sigma Stat software. Data are analyzed by multiple comparisons and expressed as mean ± SD. A p-value of < 0.05 was considered statistically significant.
Results
Inhibition of Tiam1-Rac1 signaling axis ameliorates p38 MAP kinase activation in diabetic mice
We have recently reported significant inhibitory effects of NSC23766, a known inhibitor of Tiam1-Rac1 signaling pathway, on Rac1 activation, Nox2 activity and ROS generation in Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry endothelial cells and the retina of diabetic mice [6] . As a logical extension we further assessed the relevance of p38 MAP kinase activation by Tiam1-Rac1 signaling axis by quantifying p38 MAP kinase activation in retina from diabetic mice treated without NSC23766 [6] . Fig. 2 (Panel A) demonstrated ~50% increase in p-p38 MAP kinase in the retina from the diabetic mice, which was completely abrogated in diabetic mice receiving NSC23766, an inhibitor of Tiam1-Rac1 signaling pathway, soon after induction of diabetes. Furthermore, NSC23766 administration also decreased its diabetes-induced increased localization of p38 MAP kinase in the retinal vasculature (Panels B and C), as evidenced by the decreased intensity of the immunostaining.
Tiam1-Rac1 signaling pathway mediates glucose-mediated activation of p38 MAP kinase in retinal endothelial cells
Within 3 hours of incubation of endothelial cells with high glucose, p38 MAP kinase was activated by ~50% ( Fig. 3 ; Panel A), which remained at that level for up to 96 hours of incubation ( Fig. 3; Panel B ). NSC23766 abolished glucose-induced activation of p38 MAP kinase at both 3 and 96 hour time points. It is noteworthy that NSC23766 has been shown to inhibit glucose-induced Rac1 activation in endothelial cells under these conditions [6] . Together, these results suggest that p38 MAP kinase represents one of the downstream signaling events mediated by Tiam1-Rac1 signaling pathway under the duress of hyperglycemic conditions.
Inhibition of protein palmitoylation attenuates glucose-mediated activation of Nox2 and ROS generation
We next assessed if palmitoylation-derived activation of proteins (e.g., Rac1) regulates Nox2 activation in high glucose conditions, since Rac1 is an integral part of holoenzyme Palmitoylation is requisite for glucose-induced Rac1 activation As stated above, the majority of small molecular mass G-proteins undergo posttranslational modifications at their C-termini, including palmitoylation ( Fig. 1) . Such modifications render the modified G-proteins more hydrophobic, thereby enabling them to translocate to the membrane for the interaction/activation of their respective effector proteins [7] [8] [9] [10] . Therefore, we asked if a palmitoylation-dependent signaling mechanism could be playing a role in Rac1 activation. Data shown in Fig. 5 indicate a significant increase in the activation of Rac1 (GTP-bound configuration) in cells incubated with high glucose for 3-96 hours, and addition of 2-BP completely inhibited glucose-induced Rac1 activation without significantly affecting Rac1 activation under basal conditions. These findings suggest that a palmitoylation-dependent signaling step controls Rac1 activation by high glucose in retinal endothelial cells.
Inhibition of palmitoylation suppresses glucose-induced p38 MAP kinase
To determine the regulatory role of palmitoylation in p38 MAP kinase activation, effect of 2-BP on p38 MAP kinase was investigated. Data in Fig. 6 
Inhibition of palmitoylation attenuates glucose-induced mtDNA damage and accelerated capillary cell apoptosis
Since our recent results have shown that Nox2-mediated increase in ROS damages mitochondria and initiates the apoptotic process, the effect of 2-BP on mtDNA damage and cell apoptosis was investigated in cells exposed to high glucose for 96 hours. As shown in Fig. 7 (Panel A) , addition of 2-BP ameliorated increase in mtDNA damage, as evidenced by amelioration of decrease in the ratio of 13.4kb and 210bp amplicons. In the same cell preparations, 2-BP decreased cell apoptosis (panel B). However, addition of 2-BP in 5mM glucose medium had no effect on either mtDNA damage or cell apoptosis.
Discussion
In the pathogenesis of diabetic retinopathy, although increase in ROS is an early event, mitochondrial damage is not observed till the duration of diabetes is extended. Our recent studies have shown that the Tiam1-Rac1-Nox2 signaling module is activated in the initial stages of diabetes to increase intracellular ROS levels leading to mitochondrial damage and accelerated capillary cell apoptosis [6] . In the current study, we employed NSC23766, a specific inhibitor of Rac1, but not Cdc42 and RhoA [12] , to further assess the roles of Tiam1, a known guanine nucleotide exchange factor for Rac1, in glucose-induced p38MAPK activation. We also demonstrated recently that NSC23766 selectively inhibits glucose-induced Rac1-Nox2-ROS signaling pathway in retinal endothelial cells [6] . As a logical extension of these findings, we undertook the current investigation to identify potential downstream signaling events to this pathway. Our findings suggest that: [i] inhibition of Tiam1-Rac1-Nox2 pathway (NSC23766) significantly attenuates hyperglycemia-induced p38 MAP kinase in the retina and its capillary cells and [ii] 2-BP, an irreversible inhibitor of S-acyltransferase, markedly attenuates Rac1-Nox2-p38 MAP kinase cascade. Collectively, these findings implicate novel roles for protein palmitoylation in the early signaling events which lead to the capillary cell apoptosis and the development of diabetic retinopathy.
Several recent studies have implicated accelerated p38 MAP kinase in metabolic dysregulation of retinal function in diabetes. Significant increases in p38 MAP kinase, ERK and inducible nitric oxide synthase (iNOS) activities have been reported in human retinal pigmented epithelial cells exposed to high glucose, and inhibition of p38 MAP kinase leads to significant reduction in iNOS gene expression and cell dysfunction. These studies have implicated damaging roles for MAP kinase in dysregulation of retinal pigment epithelial cells [37] . Using a specific inhibitor of p38 MAP kinase, Du et al. have shown an important role of MAP kinase in the development of early stages of diabetic retinopathy, and the mechanism appears to be via regulation of inflammation in the retina [38] . MAP kinase is also implicated in alterations in tight junction proteins, leukocyte adhesion, blood retinal barrier breakdown, and in the proNGF-mediated retinal neuronal apoptosis [39, 40] , some of the early functional and structural abnormalities associated with diabetic retinopathy [41, 42] . We have shown that MAP kinase plays a significant role in activation of small molecular weight G-protein, H-Ras-mediated activation of matrix metalloproteinase-9 (MMP-9) in retinal capillary cells in diabetes; activated MMP-9 damages the mitochondria, allowing cytochrome-C to leak out and initiate the apoptosis process [25, 26, 43, 44] , a phenomenon which precedes the development of histopathology characteristic of diabetic retinopathy [45] . Collectively, these studies implicate novel regulatory roles for p38 MAP kinase in the development of diabetic retinopathy.
Our current findings identify Tiam1-Rac1-Nox2 signaling axis as an upstream event in induction of p38 MAP kinase in retinal endothelial cells exposed to high glucose in vitro; our in vivo findings in retina from the diabetic mice confirmed these in vitro observations. We show that p38 MAP kinase is activated under the duress of high glucose within 3 hours of exposure and continues to be active till 96 hours of exposure. Furthermore, NSC23766, a known inhibitor of Tiam1-Rac1-Nox2 signaling pathway in the retina from diabetic mice [6] , significantly attenuates p38 MAP kinase. Thus, these data establish a link between these two signaling pathways. More importantly, since the activation of p38 MAP kinase is demonstrable at a time point (3 hours) , much earlier than the onset of mitochondrial dysfunction [4, 5] , these data suggest that Nox2 signaling pathway-mediated increase in The current study also provide compelling evidence to implicate modulatory roles for protein palmitoylation in the onset of metabolic dysfunction induced by hyperglycemic conditions. Protein palmitoylation, catalyzed by S-acyltransferase, involves incorporation of palmitate into cysteine residues via a thioester linkages [7, 8] . Palmitoylation of small G-proteins takes place at cysteine residues upstream to prenylated cysteines [7, 8] . Using pharmacological and radiometric approaches, we have reported previously that H-Ras undergoes palmitoylation in the pancreatic islet β-cell, and that such a signaling step is necessary for iNOS gene expression and subsequent NO release under conditions of exposure to proinflammatory cytokines (IL-1β) [15, 46] . We have also demonstrated enhanced translocation of H-Ras to the membrane fraction, specifically into the caveolin-1 enriched lipid rafts. In this context, Navarro-Lerida and associates have reported palmitoylation of Rac1 at cysteine-178 residue and that such a modification is requisite for GTP-loading and membrane association of Rac1 [17] . 2-BP significantly attenuates GTP-loading and membrane-association of Rac1 suggesting requisite nature of palmitoylation in the regulation of Rac1 function [17] . Data accrued in our current investigations suggest that a palmitoylation-dependent signaling step is involved in high glucose-induced Rac1-Nox2-p38 MAP kinase signaling cascade. These conclusions are based on our findings that in pancreatic beta cells, 2-BP inhibits Rac1 activation, Nox2 activity and p38 MAP kinase phosphorylation and activation [28] . It should be noted that several cellular proteins, including Rac1 and Ras undergo palmitoylation. 2-BP is used in the current studies to determine if palmitoylation is one of the regulatory steps involved in high glucose-induced p38 MAP kinase activation. Our findings indicate that it inhibits glucose-induced Rac1 and p38 MAPK activation. Additional studies are needed, however, to conclusively demonstrate that palmitoylation of Rac1 mediates these signalling steps. These include quantification of high glucose-induced Fig. 8 . Our proposed model for involvement of Tiam1-Rac1 signaling pathway in the activation of Nox2 and downstream stress kinase, leading to mitochondrial dysfunction and retinal capillary cell apoptosis, and the development of diabetic retinopathy. Based on our recently published evidence [6] and the current findings, we propose a model to highlight the contributory roles of Nox2 in cellular dysfunction induced by hyperglycemia. Chronic exposure of cells to these conditions culminates in the generation of Rac1-Nox2-mediated ROS, which, in turn, leads to activation of stress kinases (p38 MAP kinase) and onset of mitochondrial dysregulation [6] . Alterations in mitochondrial function including leakage of proapoptotic factors (cytochrome-C) into the soluble compartment leads to activation of caspases, which is turn, catalyze the degradation and mislocalization of key structural proteins leading to metabolic dysfunction of the cell. Pharmacological evidence (NSC23766 and gp91 ds-tat peptide; ref. 6 and current studies) strongly favors the concept that Tiam1-Rac1-Nox2 axis represents one of the areas for the development of novel therapeutics to impede metabolic defects under glucotoxic and diabetic conditions [6] . Our current observations also implicate that protein palmitoyltransferase might represent a potential target for halting glucotoxic effects on retinal endothelial cells and the onset of diabetic retinopathy. 
Cellular Physiology and Biochemistry
Rac1-Nox2-ROS-p38 MAPK signaling steps in endothelial cells expressing the palmitoylation resistant mutant of Rac1 (C178S Rac1) or in cells following siRNA-mediated knockdown of acyltransferase. Over expression of constitutively active (V12Rac1) and dominant negative (N17Rac1) might provide additional strength to our hypothesis. These studies, which are outside the framework of the current studies, are being pursued currently. Future studies, including those involving palmitoylation-resistant (C178S Rac1), constitutively active (V12Rac1) and dominant negative (N17Rac1) mutants of Rac1 and/or siRNA-mediated knock down of S-acyltransferase will conclusively validate our hypothesis that Rac1 palmitoylation and activation (GTP-loading) are necessary for its translocation to the organized membrane compartments leading to the assembly of Nox2 holoenzyme, ROS generation and metabolic dysregulation of retinal endothelial cells.
In summary, our current study suggest that hyperglycemic conditions promote activation of Tiam1-Rac1-Nox2 signaling module during early stages of diabetic retinopathy, which leads to activation of stress kinases such as the p38 MAP kinase (Fig. 8 ). This, in turn, leads to mitochondrial damage resulting in cell apoptosis and the development of diabetic retinopathy. We also propose that palmitoylation of specific signaling proteins (Rac1 and others yet to be identified) represent an important signaling event in this cascade. Thus, strategies to attenuate these signaling steps could offer methods to inhibit the development and progression of retinopathy in the early stages of the disease, thus sparing diabetic patients from losing their sight as a result of this devastating disease.
